Form 4: BioLife Solutions CFO Sells Shares for Tax Obligations

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 990 shares of common stock at $25.59 per share to cover tax withholding obligations.

Summary

• Troy Wichterman, Chief Financial Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 990 shares of common stock.
• The shares were sold at a price of $25.59 per share.
• The sale was executed on January 6, 2026.
• Following this transaction, Mr. Wichterman beneficially owns 150,746 shares of common stock.
• The sale was conducted under a Rule 10b5-1(c) trading plan, which was adopted on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, pre-scheduled sale by an insider to cover tax obligations, which is a neutral event and does not indicate a change in sentiment towards the company's prospects.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Troy Wichterman, Chief Financial Officer, sold 990 shares of BioLife Solutions common stock for $25.59 per share on January 6, 2026, to cover tax withholding obligations related to restricted stock vesting. This is a transaction between an officer and the company's equity, executed under a Rule 10b5-1 plan.

Stakeholder Impact

• Shareholders: The sale of 990 shares by a CFO is a minor transaction relative to the company's total outstanding shares and is unlikely to have a significant impact on the company's stock price or shareholder value. It represents a routine personal financial event for the executive.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled sale of a relatively small number of shares by the CFO to cover tax obligations associated with restricted stock vesting. Such transactions are common and do not typically signal a change in the company's fundamentals or management's outlook. Therefore, it provides no new information that would warrant a change in an existing investment thesis, suggesting a 'hold' recommendation for current investors.

Keywords

BioLife Solutions, BLFS, Form 4, Insider Trading, Stock Sale, CFO, Troy Wichterman, Rule 10b5-1, Tax Withholding, Restricted Stock